Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-24-014429
Filing Date
2024-03-21
Accepted
2024-03-20 20:55:15
Documents
6
Effectiveness Date
2024-03-21

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ny20024346x2_s8.htm S-8 67053
2 EXHIBIT 5.1 ny20024346x2_ex5-1.htm EX-5.1 79170
3 EXHIBIT 23.1 ny20024346x2_ex23-1.htm EX-23.1 1801
4 EXHIBIT 23.2 ny20024346x2_ex23-2.htm EX-23.2 1688
5 FILING FEES TABLE ny20024346x2_ex107.htm EX-FILING FEES 15319
6 logo_cooley.jpg GRAPHIC 87668
  Complete submission text file 0001140361-24-014429.txt   287074
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278121 | Film No.: 24769207
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)